Abbott Laboratories (ABT) vs Eli Lilly and Company (LLY)
A side-by-side comparison of Abbott Laboratories and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
ABT
Abbott Laboratories
$108.03HealthcareDelayed quote: Jul 29, 2026, 3:59 PM EDT
LLY
Eli Lilly and Company
$1,210.38HealthcareDelayed quote: Jul 29, 2026, 3:59 PM EDT
Total return — ABT vs LLY
growth of $100 · dividends reinvested · last 30yABT +1976.1%LLY +8814.0%LLY compounded faster
ABT LLY
ABT vs LLY: by the numbers
- •LLY is the larger company ($1.14T vs $188.16B market cap).
- •ABT trades at the lower trailing earnings multiple (34.51 vs 43.43 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 11.65% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 2.98% CAGR).
- •ABT pays the higher dividend yield (2.27% vs 0.53%).
Metrics side by side
Valuation
| Metric | ABT | LLY |
|---|---|---|
| P/E ratio | 34.51 | 43.43 |
| Forward P/E | 19.47 | 34.81 |
| P/S ratio | 4.02 | 15.16 |
| P/B ratio | 3.60 | 35.11 |
| PEG ratio | 4.20 | 0.49 |
| EV / EBITDA | 21.69 | 32.62 |
| FCF yield | 3.94% | 1.24% |
Profitability
| Metric | ABT | LLY |
|---|---|---|
| Gross margin | 56.80% | 83.51% |
| Operating margin | 17.03% | 45.87% |
| Net margin | 11.65% | 34.98% |
| ROE | 10.42% | 81.01% |
| ROIC | 8.43% | 30.20% |
Dividends
| Metric | ABT | LLY |
|---|---|---|
| Dividend yield | 2.27% | 0.53% |
| Payout ratio | 65.24% | 28.09% |
Growth (annualized)
| Metric | ABT | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 23.17% |
| EPS CAGR (5Y) | 8.22% | 28.88% |
| FCF CAGR (5Y) | 5.26% | 19.54% |
| Total return CAGR (5Y) | -0.37% | 39.06% |
Frequently asked
- Which has the lower trailing P/E, ABT or LLY?
- ABT has the lower trailing P/E: ABT trades at 34.51 and LLY at 43.43. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABT or LLY?
- Over the past five years, LLY grew revenue faster — ABT at a 2.98% CAGR versus LLY at 23.17%.
- Does ABT or LLY pay a bigger dividend?
- ABT yields 2.27% and LLY yields 0.53% based on trailing dividends and the latest price.
- Is ABT or LLY more profitable?
- LLY runs the higher net margin — ABT at 11.65% versus LLY at 34.98%.
- How have ABT and LLY total returns compared?
- Over the past 10 years, ABT delivered 11.29% and LLY delivered 33.01% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioEli Lilly and P/E ratioAbbott Laboratories dividend yieldEli Lilly and dividend yieldAbbott Laboratories ROEEli Lilly and ROEAbbott Laboratories operating marginEli Lilly and operating marginAbbott Laboratories revenue growthEli Lilly and revenue growthAbbott Laboratories free cash flowEli Lilly and free cash flow
Abbott Laboratories & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.